Helsinki Business and Science Park (HBSP) provides a dynamic business environment with a diversified research and expert network and a Centre of Expertise within biotechnology, drug development and diagnostics, as well as food and environmental technology. Our objective is to improve the success opportunities of Finnish companies on the international market, and to improve domestic competitiveness.
Hermo Pharma Ltd. today announced that The Michael J. Fox Foundation has awarded an additional research grant to Professor Mart Saarma at the University of Helsinki.